Related references
Note: Only part of the references are listed.The Bim Deletion Polymorphism Clinical Profile and its Relation With Tyrosine Kinase Inhibitor Resistance in Chinese Patients With Non-Small Cell Lung Cancer
Mingchuan Zhao et al.
CANCER (2014)
Clinical Significance of BIM Deletion Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation
Kazutoshi Isobe et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
King Pan Ng et al.
NATURE MEDICINE (2012)
Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
G. M. A. Ajabnoor et al.
CELL DEATH & DISEASE (2012)
Bim Protein Degradation Contributes to Cisplatin Resistance
Juan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification
J. Tanizaki et al.
ONCOGENE (2011)
Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development
Jyh-Cherng Yu et al.
BREAST CANCER RESEARCH (2011)
Hypoxia Suppression of Bim and Bmf Blocks Anoikis and Luminal Clearing during Mammary Morphogenesis
Kelly A. Whelan et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways
Mohamed Rahmani et al.
BLOOD (2009)
Molecular Subtypes of Breast Cancer Emerging in Young Women in Taiwan: Evidence for More Than Just Westernization as a Reason for the Disease in Asia
Ching-Hung Lin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic
Mark S. Cragg et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Westernizing women's risks? Breast cancer in lower-income countries
Peggy Porter
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM
J. A. Wickenden et al.
ONCOGENE (2008)
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion
Jing Deng et al.
CANCER RESEARCH (2007)
Anoikis, initiated by Mcl-1 degradation and bim induction, is deregulated during oncogenesis
Nicholas T. Woods et al.
CANCER RESEARCH (2007)
Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas
Yixuan Gong et al.
PLOS MEDICINE (2007)
BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations
Daniel B. Costa et al.
PLOS MEDICINE (2007)
Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics
Mark S. Cragg et al.
PLOS MEDICINE (2007)
Early- and late-onset breast cancer types among women in the United States and Japan
Rayna K. Matsuno et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms
Arnaud A. Mailleux et al.
DEVELOPMENTAL CELL (2007)
Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002
Xueling Sim et al.
BMC CANCER (2006)
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic (vol 103, pg 14907, 2006)
Junya Kuroda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic
Junya Kuroda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation
JS Lewis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis
YC Shen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes
MJ Reginato et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy
TT Tan et al.
CANCER CELL (2005)
Bim is a suppressor of Myc-induced mouse B cell leukemia
A Egle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis
MJ Reginato et al.
NATURE CELL BIOLOGY (2003)
Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis
H Puthalakath et al.
SCIENCE (2001)
Share Paper
